FDA

Page 3 of 35

Semaglutide medications Wegovy and Ozempic are pictured
Health

Wegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers

By Bloomberg, Madison Muller, Ike Swetlitz and Naomi Kresge
February 21, 2025
A woman takes pills at her desk
Health

The dietary supplements you think are improving your health may be damaging your liver, research warns

By
February 19, 2025
Trump administration cuts reach FDA employees in food safety, medical devices and tobacco products
Health

Trump administration cuts reach FDA employees in food safety, medical devices and tobacco products

By Matthew Perrone and The Associated Press
February 17, 2025
A woman holds a medicine bottle while reading instructions.
Health

Gen Z’s expensive drug habit: More want brand-name meds that are 79% more expensive

By
February 15, 2025
Doctor analyzes health care data
Health

Judge tells CDC, FDA to restore webpages and data removed after Trump’s executive order

By The Associated Press and Michael Kunzelman
February 11, 2025
A woman injects herself with medication.
Health

Ozempic, Wegovy maker calls out Hims & Hers Super Bowl ad: ‘Check before you inject’

By
February 11, 2025
A young woman undergoes a brain scan.
Aging Well

Meet the 24-year-old helping Lilly test a preventive Alzheimer’s drug

By
February 6, 2025
A person stands on a scale.
Health

Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs

By
February 3, 2025
Close-up view of man in blue button-down shirt placing pills in his hand.
Health

New pain drug, Vertex’s Journavx, gets FDA approval as safer alternative to addictive opioids

By Bloomberg and Gerry Smith
January 31, 2025
The increase in online searches for obesity management drugs in recent years correlated to a surge in dispensed prescriptions, according to a new study from the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease.
Health

Online searches predicted the surge in prescriptions of weight-loss drugs like Wegovy and Zepbound, study says. Here’s what could happen next

By
January 29, 2025
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.
Health

Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

By
January 22, 2025
woman pouring milk from one container into another outside, with a cow in the background
Health

Raw milk, touted by RFK Jr. and costing up to $21 a gallon, is under fire because of bird flu. What science says about the benefits and risks

By
January 17, 2025
A pile of candy hearts with messages written on them for Valentine's Day
Health

What foods have Red dye 3? Candy Corn, red icing, and other favorite snacks

By The Associated Press and Hallie Steiner
January 16, 2025
FDA bans red dye No. 3 from foods, supplements, and some medicines because of potential cancer risk
Health

FDA bans red dye No. 3 from foods, supplements, and some medicines because of potential cancer risk

By
January 15, 2025
Modern-day hippie moms have found solace in one Trump appointee: RFK Jr.
Lifestyle

Modern-day hippie moms have found solace in one Trump appointee: RFK Jr.

By
December 4, 2024

Most Popular